Ansell Limited (ANSLF)

USD 18.0

(0.0%)

EBITDA Summary of Ansell Limited

  • Ansell Limited's latest annual EBITDA in 2024 was 209.86 Million USD , down -23.37% from previous year.
  • Ansell Limited's latest quarterly EBITDA in 2024 FY was N/A , up 3.19% from previous quarter.
  • Ansell Limited reported an annual EBITDA of 264 Million USD in 2023, down -10.67% from previous year.
  • Ansell Limited reported an annual EBITDA of 287.44 Million USD in 2022, down -27.63% from previous year.
  • Ansell Limited reported a quarterly EBITDA of 51.65 Million USD for 2024 Q1, down -65.78% from previous quarter.
  • Ansell Limited reported a quarterly EBITDA of N/A for 2024 FY, up 3.19% from previous quarter.

Annual EBITDA Chart of Ansell Limited (2024 - 1989)

Historical Annual EBITDA of Ansell Limited (2024 - 1989)

Year EBITDA EBITDA Growth
2024 209.86 Million USD -23.37%
2023 264 Million USD -10.67%
2022 287.44 Million USD -27.63%
2021 397.74 Million USD 45.99%
2020 284.38 Million USD 21.3%
2019 199.48 Million USD 1.82%
2018 198.81 Million USD 0.06%
2017 230.16 Million USD -6.21%
2016 243.7 Million USD 13.88%
2015 211.93 Million USD -0.97%
2014 214.01 Million USD 25.22%
2013 185.44 Million USD -7.32%
2012 182.56 Million USD -3.11%
2011 178.46 Million USD 52.19%
2010 146.88 Million USD 6.15%
2009 117.81 Million USD -23.29%
2008 160.26 Million USD 35.31%
2007 113.5 Million USD 16.75%
2006 127.78 Million USD -7.49%
2005 105.09 Million USD 19.2%
2004 112.43 Million USD 7.12%
2003 116.97 Million USD -4.73%
2002 86.38 Million USD 65.98%
2001 52.04 Million USD 54.83%
2000 33.61 Million USD -75.22%
1999 135.65 Million USD 59.56%
1998 85.02 Million USD -43.53%
1997 200.78 Million USD 42.66%
1996 133.73 Million USD -43.32%
1995 261.22 Million USD -38.43%
1994 415.32 Million USD 27.45%
1993 353.79 Million USD -12.17%
1992 362.56 Million USD -2.69%
1991 362.04 Million USD -27.46%
1990 499.09 Million USD 28.51%
1989 388.36 Million USD 0.0%

Peer EBITDA Comparison of Ansell Limited

Name EBITDA EBITDA Difference
American Medical Technologies Inc. -963.95 Thousand USD 21870.884%
Ansell Limited 206.3 Million USD -1.726%
BG Medicine, Inc. - USD -Infinity%
Biotage AB (publ) 42.83 Million USD -389.875%
BioLife Sciences Inc. - USD -Infinity%
CB Scientific, Inc. -1.62 Million USD 13014.932%
Psykey, Inc. -1.29 Million USD 16301.703%
ConvaTec Group Plc 455.5 Million USD 53.927%
ConvaTec Group Plc 455.5 Million USD 53.927%
Encision Inc. -544.19 Thousand USD 38663.623%
Golden Valley Development, Inc -141.81 Thousand USD 148087.667%
Hear AtLast Holdings, Inc. -109.93 Thousand USD 191004.494%
Innovative MedTech Inc. -7.67 Million USD 2834.771%
LifePoint, Inc. -14.2 Million USD 1577.674%
Medite Cancer Diagnostics, Inc. -6.18 Million USD 3491.972%
Paradigm Medical Industries, Inc. -325 Thousand USD 64672.711%
QuantRx Biomedical Corporation - USD -Infinity%
Remedent, Inc. -215.23 Thousand USD 97603.791%
Reflect Scientific, Inc. -405.78 Thousand USD 51817.493%
SmileDirectClub, Inc. -186.13 Million USD 212.744%
Sector 10, Inc. - USD -Infinity%
Shandong Weigao Group Medical Polymer Company Limited 447.82 Million USD 53.138%
SheerVision, Inc. -110.53 Thousand USD 189966.472%
United Health Products, Inc. -2.5 Million USD 8487.025%
Vasamed, Inc. -4.57 Million USD 4687.692%
Wearable Health Solutions, Inc. -2.26 Million USD 9382.876%
Yubo International Biotech Limited -1.17 Million USD 17919.802%